Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

Eikelboom, John W., Connolly, Stuart J., Brueckmann, Martina, Granger, Christopher B., Kappetein, Arie P., Mack, Michael J., Blatchford, Jon, Devenny, Kevin, Friedman, Jeffrey, Guiver, Kelly, Harper, Ruth, Khder, Yasser, Lobmeyer, Maximilian T., Maas, Hugo, Voigt, Jens-Uwe, Simoons, Maarten L., Van de Werf, Frans·2013·New England Journal of Medicine
DOI 10.1056/nejmoa1300615

Cited by (1,000)

Items 801–900 of 1,000

  1. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding
    Federico Barocelli, Stefano Coli, Antonio Crocamo, Angela Guidorossi, Maria Alberta Cattabiani, Francesca Preti, Davide Bosi, Cristina Spaziani, Daniela Lina, Alberto Menozzi et al. · 2020 · Journal of Cardiovascular Medicine
  2. Anticoagulants oraux directs : dans quelles indications ? Lequel prescrire ? Pour ou contre chez les personnes fragiles et dans les situations atypiques ? Quelle surveillance et gestion des accidents hémorragiques ?
    Clément Hoffmann, Cyril Leven, Raphaël Le Mao, Claire DE MOREUIL, Karine Lacut · 2020 · La Revue de Médecine Interne
  3. Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care
    Naeem Alshoaibi, Mousa Al Harbi, H Modaimegh, Atif AlQubbany, Sardar Adnan Saif, Derek Leslie Connolly, Suleiman M. Kharabsheh, M Fathy, Y Hegazy, Nadine Tarcha et al. · 2021 · Expert Review of Cardiovascular Therapy
  4. The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways
    Kori Leblanc, Jenny MacGillivray, Amanda Carroccia, Laurent Macle, Jason G. Andrade · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
  5. Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines – Atrial Fibrillation (GWTG-AFIB) registry
    Aditya J. Ullal, DaJuanicia N. Holmes, Barbara L. Lytle, Roland Matsouaka, Shubin Sheng, Nihar R. Desai, Anne B. Curtis, Margaret C. Fang, Pamela J. McCabe, Gregg C. Fonarow et al. · 2021 · American Heart Journal
  6. Recent Advances in Thrombosis and Hemostasis – Part III
    Sam Schulman · 2018 · Seminars in Thrombosis and Hemostasis
  7. Antithrombotic treatment for valve prostheses: Which drug, which dose, and when?
    Elisabetta Ricottini, Annunziata Nusca, Gian Paolo Ussia, Francesco Grigioni · 2022 · Progress in Cardiovascular Diseases
  8. Rapidly Progressive and Catastrophic Calciphylaxis After Mechanical Valve Replacement
    Philippe Fernand Nyembo, Keith E. Eidman, Mengistu A. Simegn, Andrew W. Shaffer, Gautam R. Shroff · 2022 · JACC Case Reports
  9. Direct Oral Anticoagulants: Navigating Through Clinical Challenges
    Maria Ioannou, Elena Leonidou, Ioanna Chaziri, Angeliki Mouzarou · 2023 · Cardiovascular Drugs and Therapy
  10. The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations
    Anna Plitt, Sameer Bansilal · 2017 · Journal of Atrial Fibrillation
  11. Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation
    Yōichi Sasaki, Ryotaro Sakamori, Ryoko Yamada, Minoru Shigekawa, Yuki Tahata, Yuki Makino, Tasuku Nakabori, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi et al. · 2019 · Hepatology Research
  12. When to Refer Patients for Left Atrial Appendage Closure
    Christopher Randall Ellis, Gregory G. Jackson · 2019 · Cardiac Electrophysiology Clinics
  13. Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
    Mahmoud Hassan Abdelnabi, Abdallah Mostafa Almaghraby, Yehia Saleh · 2020 · European Cardiology Review
  14. Nonvitamin K oral anticoagulants in cardiac surgery: What cardiothoracic surgeons need to know 2.0
    Stephen D. Waterford, Niv Ad · 2021 · Journal of Thoracic and Cardiovascular Surgery
  15. Drive-Through Anticoagulation Clinic During the COVID-19 Pandemic
    Jean Giver, Amy L. Dunn, Amanda D. Sankar, Joseph R. Stanek, Kay L. Monda, Joan Canini, Bryce A. Kerlin, Vilmarie Rodriguez · 2021 · The Journal for Nurse Practitioners
  16. Advances in Clinical Cardiology
    Andrew H. McNeice, Neil M. McAleavey, Ian B A Menown · 2014 · Advances in Therapy
  17. Reply
    Zachary Louis Steinberg, Eric V. Krieger · 2017 · Journal of the American College of Cardiology
  18. Is aspirin needed to prevent thrombotic events in patients treated with a HeartMate 3 left ventricular assist device?
    Finn Gustafsson · 2020 · The Journal of Heart and Lung Transplantation
  19. Rivaroxaban versus vitamin K antagonist treatment on the progression of coronary calcification: the IRIVASC-trial
    Robert Stöhr, Sebastian Daniel Reinartz, Timm Dirrichs, Klaus Karl Witte, Alexander Schuh, Vincent Mathias Brandenburg · 2024 · Scientific Reports
  20. A global survey on practice changes and barriers to the use of direct oral anticoagulants in children
    Laura Avila, Erica Di Ruggiero, Jennifer Vincelli, Leonardo Rodrigues Brandão · 2025 · Blood Advances
  21. How should we manage left atrial thrombosis?
    Laurent Fauchier, Ariel A. Cohen · 2020 · Archives of cardiovascular diseases
  22. A Case of Unexplained Warfarin Resistance: A Case Report and Literature Review
    Maryam Favaedi, Yeganeh Pasebani, Ali Kabiri, Ali Rafati, Somayeh Jalali, Azam Kiani, Ronak Ahmadi, Aghdas Shadmehr, Aram Amirmazloomi, Zahra Khajali · 2024 · The Journal of Tehran University Heart Center
  23. A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization
    Ling Xue, Guangda Ma, Nicholas H. G. Holford, Qiong Qin, Yinglong Ding, Jacqueline A. Hannam, Xiaoliang Ding, Hongyou Fan, Zhenchun Ji, Biwen Yang et al. · 2024 · Clinical Pharmacology & Therapeutics
  24. A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention
    Arianna Cella, Alessandro Marè, Gian Luigi Gigli, Marialuisa Zedde, Mariarosaria Valente, Giovanni Merlino · 2024 · Expert Opinion on Drug Metabolism & Toxicology
  25. Direct Oral Anticoagulants Versus Vitamin K Antagonists After Mitral Valve Transcatheter Edge‐to‐Edge Repair in Patients With Atrial Fibrillation: A Single‐Center Observational Study
    Jan‐Hendrik Schipper, Anne‐Sophie Sommer, Richard Julius Nies, Clemens Metze, Max M. Meertens, Jonas Wörmann, Sebastian Dittrich, Jan‐Hendrik van den Bruck, Arian Sultan, Jakob Lüker et al. · 2025 · Journal of the American Heart Association
  26. Antithrombotic Treatment for Left Ventricular Assist Devices: One Does Not Fit All
    Emmanuelle Scala, Alexandra Othenin‐Girard · 2025 · Hämostaseologie
  27. Oral anticoagulation in patients with atrial fibrillation and heart valve prosthesis: A substudy from the Left Atrial Appendage Occlusion Study (LAAOS) III trial
    Domenico Paparella, Emilie P. Belley‐Côté, Michele Di Mauro, Enrico Squiccimarro, Martina Macella, Katheryn Brady, Michael W.A. Chu, Richard Paul Whitlock · 2025 · Journal of Thoracic and Cardiovascular Surgery
  28. Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
    Matthias Hammwöhner, Andreas Goette · 2020 · European Heart Journal Supplements
  29. Meta-Analysis Comparing Direct Oral Anticoagulants to Vitamin K Antagonists for The Management of Left Ventricular Thrombus
    Hesham K. Abdelaziz, Michael S. Megaly, Maciej Dębski, Amr Abdelrahman, Shehab Abdelaziz, Diaa Kamal, Billal Patel, Ranjit S More, Tawfiq R Choudhury · 2021 · Expert Review of Cardiovascular Therapy
  30. Cardioembolic stroke: classification of causes and prevention strategies
    Andrei Viktorovich Fonyakin, Л.А. Гераскина · 2021 · Neurology neuropsychiatry Psychosomatics
  31. Antithrombotika und Antihämorrhagika
    Lutz Hein, Hans Wille · 2020 · Springer eBooks
  32. A qualitative study exploring patient experiences and opinions of warfarin patient self‐management in the US healthcare system
    Aaron S. Wilson, Stacey L. Slager, Aubrey E. Jones, Sara R. Vazquez, Geoffrey D. Barnes, Katelyn Woods Sylvester, Linh Chan, Bishoy Ragheb, Daniel M. Witt · 2023 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  33. Correlation between Metabolic Parameters and Warfarin Dose in Patients with Heart Valve Replacement of Different Genotypes
    Xiaowu Wang, Diancai Zhao, Jipeng Ma, Xia Wang, Jincheng Liu · 2024 · Reviews in Cardiovascular Medicine
  34. The current landscape of factor XI inhibitors
    Matthias M. Engelen, Charlotte J. Van Edom, Andreas Verstraete, Peter B. Verhamme, Thomas Vanassche · 2024 · Thrombosis Update
  35. Validation of large animal models in mechanical valve research: a histologic comparison
    Manon Van Hecke, Tom Langenaeken, Filip Rega, Tania Roskams, Bart Meuris · 2024 · Interdisciplinary CardioVascular and Thoracic Surgery
  36. Perioperative Management of Valvular Heart Disease in Patients Undergoing Non-Cardiac Surgery
    Yashar Jalali, Monika Jalali, Ján Števlík · 2024 · Journal of Clinical Medicine
  37. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-Analysis
    Xiaoyun Liang, Shangyu Liu, Lishuang Ji, Fangfang Ma, Guoyuan Song, Fang Li, Gang Liu · 2024 · Cardiovascular Drugs and Therapy
  38. Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair
    Isabel A. Hoerbrand, Martin J. Kraus, Martin J. Gruber, Nicolas A. Geis, Philipp Schlegel, Norbert Frey, Mathias H. Konstandin · 2024 · Clinical Research in Cardiology
  39. A review of the perioperative management of direct oral anticoagulants for pediatric anesthesiologists
    Kara Furman, Andrew James Giustini, Joshua W. Branstetter, Gary M. Woods, Laura A. Downey · 2024 · Pediatric Anesthesia
  40. Characteristics and Efficacy of Warfarin Sodium Tablet Subdivided by 3D Printing Technology: A Retrospective Cohort Study of Patients After Prosthetic Valve Replacement
    Jieqiong Lv, Kaixia Fu, Lingjuan Xiong, Bishan Chen, Luchuan Zhan, Jiang Liu, Zhanyi Lin, Fan Yang, Jisheng Chen · 2025 · Drug Design Development and Therapy
  41. Trends in Warfarin Monitoring Practices Among New York Medicare Beneficiaries, 2006–2011
    Darren M. Triller, Susan Wymer, Patrick D. Meek, Elaine M. Hylek, Jack Ansell · 2015 · Journal of Community Health
  42. Novel Oral Anticoagulants for Stroke Prevention in the Geriatric Population
    Daniel Kim, Richard Barna, Mary Barna Bridgeman, Luigi Brunetti · 2013 · American Journal of Cardiovascular Drugs
  43. New oral anticoagulants: An emergency department overview
    Peter Wood · 2013 · Emergency Medicine Australasia
  44. New advances in the treatment of atrial fibrillation: focus on stroke prevention
    Yee Cheng Lau, Gregory Y.H. Lip · 2014 · Expert Opinion on Pharmacotherapy
  45. Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients
    Job Harenberg · 2016 · Thrombosis Research
  46. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
    and Collaborators, Özcan Başaran, Volkan Doğan, Osman Beton, Mehmet Tekinalp, Ahmet Çağrı Aykan, Ezgi Kalaycıoğlu, İsmail Bolat, Onur Taşar, Özgen Şafak et al. · 2016 · Journal of Thrombosis and Thrombolysis
  47. The Prospective Randomized On-X Valve Anticoagulation Clinical Trial (PROACT): Lower is better, but is it good enough?
    Ismail Bouhout, Ismaı̈l El-Hamamsy · 2019 · Global Cardiology Science and Practice
  48. Major Bleeding Risk with Non-Vitamin K Antagonist Oral Anticoagulant vs. Aspirin in Heart Failure: Network Meta-Analysis
    Wen‐Yi Huang, Jeffrey L. Saver, Yi‐Ling Wu, Chun‐Jen Lin, Meng Lee, Bruce I Ovbiagele · 2020 · ESC Heart Failure
  49. Efficacy and Safety of Nonvitamin K Oral Anticoagulants following Cardiac Valve Replacement
    Mary Katherine Stuart, Sarah B. Blackwell, Hillary B. Holder, Elizabeth L. Wood, Jessica A. Starr · 2021 · Southern Medical Journal
  50. Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents
    Hannah Stevens, James D. McFadyen, Noel Chan · 2021 · Seminars in Respiratory and Critical Care Medicine
  51. Evaluation of Prescribing Practices and Outcomes Using Direct-acting Oral Anticoagulants After Cardiac Surgery
    Dareen M. Kanaan, Bryan M. Cook, Julie Kelly, Rhynn J. Malloy · 2021 · Clinical Therapeutics
  52. Association between time to therapeutic INR and length of stay following mechanical heart valve surgery
    Lucas C. Godoy, GEORGE A. TOMLINSON, Asmaa M. Abumuamar, Michael E. Farkouh, Madeleine Rudolph, Filio Billia, Iris Cohn, Gil Marcus, Raymond H. Kim, Vivek Rao et al. · 2021 · Journal of Cardiac Surgery
  53. Apixaban in a porcine model of mechanical valve thrombosis in pulmonary position—a pilot study
    Lucas Van Hoof, Isabelle Truyers, Hadewych Van Hauwermeiren, Bram Nachtergaele, Tom Langenaeken, Marc G Jacquemin, Filip Rega, Peter B. Verhamme, Bart Meuris · 2022 · Interactive Cardiovascular and Thoracic Surgery
  54. Over-anticoagulation by vitamin K antagonists and gender differences
    Doris Barcellona, Paola Schirru, Antonella Mameli, Simona Cornacchini, L. Fenu, Francesco Marongiu · 2022 · International Journal of Cardiology
  55. Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy
    Ho‐Jun Jang, Dongyoung Lee, Tae‐Hoon Kim, Je Sang Kim, Hyun‐Jong Lee, Ji Bak Kim, Jiyoung Kim · 2022 · PLoS ONE
  56. Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application
    Ratko Lasica, Milika Ašanin, Lazar Djukanovic, Nebojša Radovanović, Lidija Savić, Marija M. Polovina, Sanja Dj Stankovic, Arsen D. Ristić, Marija D. Zdravkovic, Andjelka Lasica et al. · 2022 · Pharmaceuticals
  57. Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery
    Dannick Brochu, Amélie St-Arnaud, Louis-Étienne Marchand, Pierre Voisine, Julie Méthot · 2022 · Journal of Cardiovascular Pharmacology and Therapeutics
  58. Anticoagulation for rheumatic mitral stenosis, INVICTUS in perspective
    Raj Verma, David A. Latter · 2022 · Current Opinion in Cardiology
  59. Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands
    Catharina CM Kager, Maaike Horsselenberg, Joke C. Korevaar, Cordula Wagner, Karin Hek · 2023 · BJGP Open
  60. Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study
    Maurizio Paciaroni, Valeria Caso, Michele Romoli, Cecilia Becattini, Alexander Salerno, Costanza Maria Rapillo, Fanny Simonnet, Davide Strambo, Isabella Canavero, Marialuisa Zedde et al. · 2023 · European Stroke Journal
  61. Health Literacy, Patient Knowledge and Adherence to Oral Anticoagulation in Primary Care
    Milena Soriano Marcolino, Thaís Lorenna Souza Sales, João Antônio de Queiroz Oliveira, Danyelle Romana Alves Rios, Thaís Marques Pedroso, Laura Caetano de Sá, Maria Auxiliadora Parreiras Martins, Antônio Luiz Pinho Ribeiro · 2023 · International Journal of Cardiovascular Sciences
  62. Clinical decisions for appropriate management of patients with atrial fibrillation
    Giuseppe Boriani, Niccolò Bonini, Jacopo Francesco Imberti, Marco Vitolo, Luigi Gerra, Marta Mantovani, Kevin Serafini, Chiara Birtolo, Enrico Tartaglia, Davide Antonio Mei · 2024 · Panminerva Medica
  63. ATRIAL FIBRILLATION FOLLOWING CARDIAC SURGERY: PATHOPHYSIOLOGY AND PREVENTION TECHNIQUES (PART 2)
    В. В. Ломиворотов, Sergey Mihailovich Efremov, Evgeny A. Pokushalov, Бобошко Владимир Александрович · 2017 · Messenger of Anesthesiology and Resuscitation
  64. Warfarin-Induced Rapid Rise in INR Post–Cardiac Surgery Is Not Associated With Increased Bleeding Risk
    Logan M. Olson, Andrea M. Nei, Ross Dierkhising, David L. Joyce, Scott D. Nei · 2019 · Annals of Pharmacotherapy
  65. Trends and Predictors of Oral Anticoagulation in Patients with Atrial Fibrillation: A Serial Cross-Sectional Study from 2011 to 2016
    Maria De Fátima De Araújo Geraldes, Eduardo Sahade Darzé, Paulo Novis Rocha · 2019 · International Journal of Cardiovascular Sciences
  66. Medical Management of Rheumatic Heart Disease
    Emmy Okello, Ify R. Mordi, Chim Choy Lang, Craig Sable, Scott Dougherty, Nigel J. Wilson · 2020 · Elsevier eBooks
  67. İnme klinik pratiğinde NOAK kullanımı: Türk Beyin Damar Hastalıkları Derneği Uzman Görüşü
    Bilgehan Atılgan Acar, Çetin Kürşad Akpınar, Zekeriya Alioğlu, Zülfikar Arlıer, Ethem Murat Arsava, Emrah Aytaç, Demet Funda Baş, Recep Baydemir, Murat Çabalar, Mehmet Uğur Çevik et al. · 2020 · Turkish Journal of Cerebrovascular Diseases
  68. Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis
    Xuan He, Yi‐Ming Chen, Yunlang Dai, Jing Zhou, Yufeng Jiang, Yafeng Zhou · 2021 · Frontiers in Cardiovascular Medicine
  69. Antikoagulation nach Herzklappenersatz
    Frederik Voss, Christoph Sucker, Jens Litmathe · 2021 · Wiener Medizinische Wochenschrift
  70. Apixaban use in an atrial fibrillation patient with double mechanical heart valves: a case report
    Jae Young Eom, Je Kyoun Shin, Chang Hee Kwon · 2021 · European Heart Journal - Case Reports
  71. Neue orale direkte Antikoagulanzien
    Sylvia K. Haas, Sebastian Schellong · 2014 · Der Internist
  72. Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres
    Aleesa A. Carter, Kori Leblanc, Amita Woods, Donna Lowe · 2015 · The Canadian Journal of Hospital Pharmacy
  73. Review of the top 5 cardiology studies of 2013-14
    Arden R. Barry, Jade E. Basaraba, Jennifer L Bong, Chloe L. McMillan, Mohamed A. Omar, Dylan M. Pollmann, Margaret L. Ackman · 2015 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
  74. Management of oral anticoagulation in the surgical patient
    Jilani Latona, Atifur Rahman · 2015 · ANZ Journal of Surgery
  75. Perioperative Management of Oral Anticoagulants: A Focus on Target-Specific Oral Anticoagulants
    Geoffrey D. Barnes, Kim Allen Eagle, James B. Froehlich · 2014 · Hospital Practice
  76. Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage
    Larry B. Goldstein · 2017 · Stroke
  77. Treatment of postoperative atrial fibrillation: The long road ahead
    Dawn S. Hui, Richard Lee · 2019 · Journal of Thoracic and Cardiovascular Surgery
  78. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey
    Stephanie Carlin, Alison M. Bond, Peter L. Gross, Alan Bell, James Demetrios Douketis, William H Geerts, J.‐P. Galanaud · 2021 · Thrombosis Research
  79. Stroke prevention in atrial fibrillation
    Robert G. Hart, John W. Eikelboom · 2014 · Neurology Clinical Practice
  80. The NOACs (Novel Oral Anticoagulants) Have Landed!
    Joseph S. Alpert · 2014 · The American Journal of Medicine
  81. On Target
    Jean M. Connors · 2016 · Circulation Heart Failure
  82. New evidence on old drugs; warfarin versus aspirin after bioprosthetic aortic valve placement
    Scott M. Stevens, John R. Doty · 2016 · Thrombosis Research
  83. Anticoagulation of pregnant women with mechanical heart valves: protecting mother or child?
    Peter B. Verhamme, Marie‐Christine Herregods, Frans Van de Werf · 2017 · European Heart Journal
  84. Anticoagulation after mechanical aortic valve implantation: is it time to act after PROACT?
    Mevlüt Çelik, Andras Peter Durko, Stuart J. Head · 2018 · Annals of Translational Medicine
  85. Prosthetic Heart Valves: More than Half a Century of Innovation—An Overview
    Asna Tabassum, Katherine G. Phillips, Fadi G. Hage, Ali Hage · 2025 · Journal of Clinical Medicine
  86. Direct Oral Anticoagulants in Valvular Diseases and Prosthetic Valves: Why Not?
    Konstantinos M Lampropoulos, Michail Penteris, Grigoris Gerotziafas · 2025 · Cardiovascular Drugs and Therapy
  87. Antithrombotic therapy in patients with atrial fibrillation: unresolved issues and future directions
    Alexander Philipp Benz, Stephanie Carlin, John W. Eikelboom · 2026 · Journal of Thrombosis and Haemostasis
  88. Novel oral anticoagulants and valvular atrial fibrillation: are they always contraindicated?
    Giuseppe Di Pasquale, Silvia Zagnoni, Letizia Riva · 2015 · Internal and Emergency Medicine
  89. Dilemmas in the use of new oral anticoagulants
    Jecko V. Thachil · 2015 · QJM
  90. Enquête prospective sur les nouveaux anticoagulants oraux en médecine libérale : un enthousiasme prudent
    C. Krieger, Dominique Stéphan, Boris Aleil · 2015 · Annales de Cardiologie et d Angéiologie
  91. Unresolved issues in the use of direct acting oral anticoagulants
    Noel Chan, Jack Hirsh · 2023 · Expert Review of Cardiovascular Therapy
  92. Evaluation and Management of Mechanical Heart Valve Dysfunction and Thrombosis
    Gary Parizher, Ambreen Fatima Ali, Paul C Cremer · 2024 · Current Cardiology Reports
  93. Aortic valve 2024: Which valve for which patient?
    Omar M. Sharaf, Thomas Mark Beaver · 2024 · Journal of Thoracic and Cardiovascular Surgery
  94. Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation
    Fengbo Xu, Guoqin Wang, Lijun Sun, Hong Cheng · 2024 · Clinical and Experimental Medicine
  95. Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations
    Anna L. Parks, Scott M. Stevens, Scott C. Woller · 2024 · Thrombosis Research
  96. Breaking boundaries: exploring recent advances in anticoagulation and thrombosis management: a comprehensive review
    Zaheer Ahmad Qureshi, Faryal Altaf, Abdur Rehman Jamil, Rimsha Siddique, Shivendra Shah · 2024 · Annals of Medicine and Surgery
  97. Thromboprophylaxis and adult congenital heart disease: The latest on indications, risk scoring and therapy
    Mariana Sousa Paiva, Jorge Ferreira, Rui T. Anjos, Michael Α. Gatzoulis · 2025 · International Journal of Cardiology Congenital Heart Disease
  98. Optimizing Anticoagulation Strategies in Patients With Atrial Fibrillation and Valvular Heart Disease: A Comprehensive Evidence-Based Review
    Dharani Swarna Deiveegan, Mohamed Salahie, Muhammad Subhan, Sam Ismail, Muhammad Abdullah Khan, Darshankumar M Raval, Usama Abbas, Beyla Betsy Baiju, Husam K. A. Abuasaker, Ruqiya Bibi · 2025 · Cureus
  99. Factor XI inhibitors are the novel promising anticoagulants in the treatment of age related thrombotic disease
    Dandan Feng, Jianchun Wang · 2025 · Frontiers in Cardiovascular Medicine
  100. Multiple and Mixed Valvular Heart Disease: State-of-the-Art
    Elsa Richard de Vesvrotte, Andreea Sorina Afana, J. Florence, Alexandre Unger, Emmanuel Gall, Solenn Toupin, Trecy Gonçalves, Paul-Jun Martial, Yohann Bohbot, Augustin Coisne et al. · 2025 · Journal of the Heart Valve Society